ArticlePharmaceuticals (Basel, Switzerland)2019

The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells.

Michela Asperti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.